Evidence map›Paper›PMID 28024403›Full record

ArticleJournal of chemical information and modeling2016

Genetic Algorithm Managed Peptide Mutant Screening: Optimizing Peptide Ligands for Targeted Receptor Binding.

Matthew D King, Thomas Long, Timothy Andersen, Owen M McDougal

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. In Silico Conotoxin Studies: Progress and Prospects.Molecules (Basel, Switzerland) · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. [β2-nicotinic acetylcholine receptor promotes development of GABANan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  7. Article
  8. Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew D KingDepartment of Chemistry and Biochemistry and ‡Department of Computer Science, Boise State University , 1910 University Drive, Boise, Idaho 83725, United States.
Thomas LongDepartment of Chemistry and Biochemistry and ‡Department of Computer Science, Boise State University , 1910 University Drive, Boise, Idaho 83725, United States.
Timothy AndersenDepartment of Chemistry and Biochemistry and ‡Department of Computer Science, Boise State University , 1910 University Drive, Boise, Idaho 83725, United States.
Owen M McDougalDepartment of Chemistry and Biochemistry and ‡Department of Computer Science, Boise State University , 1910 University Drive, Boise, Idaho 83725, United States.ORCID 0000-0002-1502-3462
Boise State University · US

Funding

VPS35 D620N inhibits autophagy through disrupted hyaluronic acid-CD44 signalingP20GM109095 · NIGMS · BOISE STATE UNIVERSITY · PI OXFORD, JULIA THOM · 2014 to 2023
$22.7M
NIGMS NIH HHS P20 GM109095
6 · The paper itself

Abstract

This study demonstrates the utility of genetic algorithms to search exceptionally large and otherwise intractable mutant libraries for sequences with optimal binding affinities for target receptors. The Genetic Algorithm Managed Peptide Mutant Screening (GAMPMS) program was used to search an α-conotoxin (α-CTx) MII mutant library of approximately 41 billion possible peptide sequences for those exhibiting the greatest binding affinity for the α

Indexed as

Peptide LibraryAlgorithmsAmino Acid SequenceAnimalsConotoxinsDrug DiscoveryHumansModels, MolecularMutationNicotinic AntagonistsProtein BindingRatsReceptors, NicotinicSoftwarealpha-conotoxin MIIConotoxinsNicotinic Antagonistsnicotinic receptor alpha3beta2Peptide LibraryReceptors, Nicotinic

Identifiers

PMID28024403
PMCPMC5367625
OpenAlexW2551539687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.